Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure
Open Access
- 6 February 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Abstract
Remnant cholesterol, identified by triglyceride-rich lipoprotein, is a significant causal risk factor for ischemic heart diseases. The association of triglyceride levels with all-cause and cause-specific outcomes in heart failure (HF) remains unexplored. Using a previously validated territory-wide clinical information registry, all eligible patients diagnosed with HF (N = 127124) from 2000 to 2020 were included. In this population-based cohort (mean age: 71.4 ± 12.2 years, 51.8% male), the association between triglyceride levels and risk of all-cause mortality and cardiovascular disease was a U-shapedḍ curve. High triglyceride levels (≥3.0 mmol/L) were associated with atherosclerotic cardiovascular disease admission or death; conversely, lower triglyceride levels (<1.2 mmol/L) were associated with higher risks of HF readmission or death. The risk of adjusted all-cause mortality reached a nadir between triglyceride levels of 1.2 mmol/L and 3.0 mmol/L. Results were externally validated in BIOSTAT-CHF. Our findings have important implications for defining the role of triglyceride levels in contributing to the diverse outcomes in patients with HF.Keywords
This publication has 48 references indexed in Scilit:
- Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk PopulationsJAMA Cardiology, 2022
- Nonaspirin nonsteroidal anti‐inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory‐wide studyCancer, 2021
- Effects of Combined Renin–Angiotensin–Aldosterone System Inhibitor and Beta-Blocker Treatment on Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from BIOSTAT-CHF and ASIAN-HF RegistriesEuropean Journal of Heart Failure, 2020
- Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)The American Journal of Cardiology, 2013
- Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: A 15-year follow-up of the Chinese Multi-provincial Cohort StudyDiabetes Research and Clinical Practice, 2012
- Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties StudyEuropean Journal of Epidemiology, 2010
- Effects of low serum triglyceride on stroke mortality: A prospective follow-up studyAtherosclerosis, 2010
- Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2009
- Sudden Death After Myocardial InfarctionJAMA, 2008
- Association Between Cholesterol Level and Mortality in Dialysis PatientsJAMA, 2004